Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eric S Y Tse Insider Profile
4 Followers
Eric S Y Tse, Chief Executive Officer, Ten Percent Owner at Sino Biopharmaceutical, holds ― shares in Sino Biopharmaceutical (Ticker: SBMFF). Most recently, Eric S Y Tse Bought $5,000,000 shares of Sino Biopharmaceutical on Apr 22, 2024 for an estimated value of 11.62M.
Eric S Y Tse has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Eric S Y Tse does not currently own shares as a corporate insider.
A breakdown of Eric S Y Tse's holdings
Insider Roles
Chief Executive Officer, Ten Percent Owner
Roles that Eric S Y Tse holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Eric S Y Tse
Eric S Y Tse's Trading History
List of latest transactions for each holding click on a transaction to see Eric S Y Tse's performance on stock
You May Also Like
Eric S Y Tse insider profile FAQ
What is the percentage of profitable transactions made by Eric S Y Tse?
The percentage of profitable transactions made by Eric S Y Tse is ―.
What is the average return per transaction made by Eric S Y Tse?
The average return per transaction made by Eric S Y Tse is ―.
What stocks does Eric S Y Tse hold?
Eric S Y Tse holds: SBMFF stocks.
What was Eric S Y Tse’s latest transaction?
Eric S Y Tse latest transaction was an Informative Buy of $11.62M.
What was Eric S Y Tse's most profitable transaction?
Eric S Y Tse’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Eric S Y Tse's role in Sino Biopharmaceutical?
Eric S Y Tse's role in Sino Biopharmaceutical is Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.